Hypoglycemic Agents: all 3,927 studies that test it

Page 11 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 DiabetesCompletedNCT01155284Phase 2Results posted
• The Suppression of Toll Like Receptors by InsulinCompletedNCT01151605Not applicableResults posted
• Effect of Rosiglitazone on the Vascular Biology of Human Fat TissueCompletedNCT01150981Phase 2Results posted
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01147627Not applicableResults posted
• Mechanisms of Insulin Facilitation of MemoryCompletedNCT01145482Not applicableResults posted
• Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset SeizuresCompletedNCT01142193Phase 3Results posted
• Normoglycemia and Neurological OutcomeTerminatedNCT01137773Phase 4Results posted
• Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular InsulinTerminatedNCT01136746Phase 3Results posted
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)CompletedNCT01135992Phase 3Results posted
• Pharmacogenomics of ThiazolidinedionesCompletedNCT01135394Not applicableResults posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01134107Phase 3Results posted
• Bioequivalence of Two Lispro FormulationsCompletedNCT01133392Phase 1Results posted
• Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)CompletedNCT01131182Phase 4Results posted
• Diabetes in the Elderly: Prospective StudyCompletedNCT01131052Phase 4Results posted
• A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263CompletedNCT01128621Phase 2Results posted
• Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCompletedNCT01123980Phase 4Results posted
• Management of Diabetes With Metformin In Patients With Chronic Heart FailureCompletedNCT01122316Not applicableResults posted
• A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsCompletedNCT01119846Phase 2Results posted
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents FailureCompletedNCT01117350Phase 4Results posted
• The Role of P-glycoprotein in Sitagliptin Clinical PharmacologyCompletedNCT01112670Phase 4Results posted
• Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in AdolescentsCompletedNCT01110434Phase 2Results posted
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump UseCompletedNCT01109316Phase 3Results posted
• Prandial Insulin Dosing in Hospitalized PatientsCompletedNCT01101867Phase 4Results posted
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerCompletedNCT01101438Phase 3Results posted
• Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin TreatmentCompletedNCT01099618Phase 4Results posted
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)CompletedNCT01093794Phase 1Results posted
• Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIVCompletedNCT01093651Phase 2/3Results posted
• The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes MellitusCompletedNCT01092663Not applicableResults posted
• Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin GlargineCompletedNCT01089569Not applicableResults posted
• Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation TherapyCompletedNCT01087736Phase 4Results posted
• Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentCompletedNCT01087502Phase 3Results posted
• Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 DiabetesCompletedNCT01084005Phase 3Results posted
• The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) TrialCompletedNCT01081834Phase 3Results posted
• A Dose-Finding Study of Topiramate (JNS019) in Participants With MigraineCompletedNCT01081795Phase 2Results posted
• Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)CompletedNCT01076088Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)CompletedNCT01076075Phase 3Results posted
• Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-AdministeredCompletedNCT01068743Phase 1Results posted
• Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy SubjectsCompletedNCT01068730Phase 1Results posted
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01059812Phase 3Results posted
• A Study for Patients With Type 1 DiabetesCompletedNCT01049412Phase 2Results posted
• Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinCompletedNCT01046110Phase 3Results posted
• Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
• Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCompletedNCT01045447Phase 3Results posted
• Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?CompletedNCT01040819Phase 4Results posted
• A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)CompletedNCT01034111Phase 3Results posted
• Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedNCT01030952Phase 4Results posted
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"CompletedNCT01030861Phase 2Results posted
• Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusCompletedNCT01029704Phase 2Results posted
• 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)CompletedNCT01028391Phase 3Results posted
• HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)CompletedNCT01023620Not applicableResults posted
• Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesCompletedNCT01023581Phase 3Results posted
• Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
• Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01009580Phase 3Results posted
• Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3Results posted
• DPP-4 Inhibition and TZD for DM PreventionTerminatedNCT01006018Not applicableResults posted
• Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of TreatmentCompletedNCT01002547Phase 4Results posted
• Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With PioglitazoneCompletedNCT00996658Phase 3Results posted
• A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory AsthmaCompletedNCT00994175Phase 2Results posted
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCompletedNCT00993473Phase 3Results posted
• Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)CompletedNCT00993187Phase 4Results posted
• Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy SubjectsCompletedNCT00986401Phase 1Results posted
• Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00984490Not applicableResults posted
• Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00979628Phase 4Results posted
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00978627Phase 3Results posted
• A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
• A Study of Insulin Lispro Mix in Type 2 Diabetic Asian PatientsCompletedNCT00971997Phase 4Results posted
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeCompletedNCT00968708Phase 3Results posted
• Prevention of Cystic Fibrosis DiabetesTerminatedNCT00967798Phase 3Results posted
• Metformin Compared to Glyburide in Gestational DiabetesCompletedNCT00965991Not applicableResults posted
• Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusCompletedNCT00957268Phase 1Results posted
• Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe PsoriasisTerminatedNCT00954915Phase 1/2Results posted
• Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00954447Phase 3Results posted
• Pioglitazone for Oral Premalignant LesionsTerminatedNCT00951379Phase 2Results posted
• Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)TerminatedNCT00947011Phase 2Results posted
• Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fed ConditionsCompletedNCT00939705Phase 1Results posted
• Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fasted ConditionsCompletedNCT00939692Phase 1Results posted
• Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney TransplantationTerminatedNCT00936663Phase 4Results posted
• Pre-Surgical Study: Effect of Metformin on Breast Cancer ProliferationCompletedNCT00930579Phase 2Results posted
• Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)CompletedNCT00929201Phase 1Results posted
• Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory FactorsCompletedNCT00928889Phase 4Results posted
• Effect of Thiazolidinediones on Human BoneCompletedNCT00927355Not applicableResults posted
• Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung CancerTerminatedNCT00923949Phase 2Results posted
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes MellitusTerminatedNCT00920582Phase 3Results posted
• Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT00916357Phase 2Results posted
• Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg BidCompletedNCT00915772Phase 3Results posted
• The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenCompletedNCT00913497Phase 4Results posted
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT00911625Phase 4Results posted
• Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00909480Phase 4Results posted
• Topiramate 25 mg Tablets Under Fasting ConditionsCompletedNCT00905606Phase 1Results posted
• Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting ConditionsCompletedNCT00905346Phase 1Results posted
• Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)CompletedNCT00897390Phase 1Results posted
• A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)CompletedNCT00888238Phase 1Results posted
• Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient IngestionCompletedNCT00885638Phase 4Results posted
• Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes MellitusCompletedNCT00885378Phase 3Results posted
• Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)CompletedNCT00885352Phase 3Results posted
• Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusCompletedNCT00883558Phase 2Results posted
• Thiazolidinedione Intervention With Vitamin D EvaluationTerminatedNCT00879970Phase 4Results posted
• Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)CompletedNCT00875394Phase 3Results posted

← Hypoglycemic Agents overview